Month: March 2022

Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022

Written by Customer Service on March 28, 2022. Posted in Public Companies.

Poster outlines data showing Oncocyte’s DetermaIO™ tool can inform therapeutic decisions and has the potential to improve outcomes for patients with bladder cancer IRVINE, Calif., March 28, 2022 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, today announced that it will present new confirmatory data on DetermaIO™, its 27-gene expression test used to identify responders to immune checkpoint inhibitor (ICI) therapies, at the American Association for Cancer Research (AACR) Annual Meeting 2022, taking place April 8-13, 2022 in New Orleans. The analysis in the poster builds on previous data, which showed that IO Score correlates with response to Genentech’s...

BIGG Digital Assets Inc. Subsidiary Netcoins Launches New Digital Assets: SHIB, DOGE, MATIC, FTM, and MANA

Written by Customer Service on March 28, 2022. Posted in Public Companies.

VANCOUVER British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), owner of Netcoins (Netcoins.ca) (“Netcoins”), the online cryptocurrency brokerage that makes it easy for Canadians to buy, sell, and understand cryptocurrency, is pleased to announce the launch of 5 new coins on the platform: SHIB, DOGE, MATIC, FTM and MANA. On March 24th, Netcoins received approval for an update to its restricted dealer license, which was requested in late 2021, enabling a broader offering of coins on the platform. These 5 coins represent the first rollout of our upcoming coin additions, with multiple rollouts expected to follow. Information on SHIB, DOGE, MATIC, FTM, and MANA can be found on coinmarketcap.com at the links below: https://coinmarketcap.com/currencies/shiba-inu/...

Enservco Corporation Reduces Debt and Strengthens Balance Sheet

Written by Customer Service on March 28, 2022. Posted in Public Companies.

DENVER, March 28, 2022 (GLOBE NEWSWIRE) — Enservco Corporation (NYSE American: ENSV), a diversified national provider of specialized well-site services to the domestic onshore conventional and unconventional oil and gas industries, today announced it has retired its $13.8 million senior revolving credit facility with East West Bank for total consideration of approximately $9.4 million, which includes an initial payment of $8.4 million in cash and future payments of up to $1.0 million from a limited portion of net proceeds from receivables financing. As a result of the refinancing, Enservco’s debt was substantially reduced and predominantly reclassified as long-term liabilities with four- to six-year terms. Equally important, the refinancing will have minimal impact on aggregate monthly debt and lease obligations, thus substantially...

ORYZON Announces Appointment of Douglas V. Faller, MD, PhD as Global Chief Medical Officer and Continues its Expansion of US Corporate Activities

Written by Customer Service on March 28, 2022. Posted in Public Companies.

Extensive academic and industry experience in hematology/oncology Will coordinate Oryzon’s global clinical development from Boston, USAMADRID, Spain and CAMBRIDGE, Mass., March 28, 2022 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today the appointment of Douglas Faller, M.D., Ph.D., to the role of Global Chief Medical Officer. Dr. Faller has over 30 years of clinical hematology/oncology expertise and broad drug development experience in the design and execution of early to registrational clinical programs across oncology and rare diseases and will lead Oryzon’s global clinical development strategy. Based in Boston, Dr. Faller will strengthen Oryzon’s...

Converge Technology Solutions Corp. To Acquire Interdynamix Systems

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

Canadian-based Interdynamix will join the Converge portfolio of companies to strengthen the Company’s engineering capabilities and services TORONTO and GATINEAU, Québec, March 28, 2022 (GLOBE NEWSWIRE) — Converge Technology Solutions Corp. (“Converge” or “the Company”) (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) a software-enabled IT & Cloud Solutions provider, is pleased to announce it has signed definitive agreements to acquire Interdynamix (IDX), a next-generation systems integrator focused on business, engineering, and innovation. The transaction is expected to close in Q2 2022. Headquartered in Alberta, Canada, Interdynamix was founded in 1995 with the goal of filling a substantial gap in the technology industry for elite engineering resources. Today, IDX is comprised of architects, engineers, sales, and support professionals....

Osisko Metals Announces Signing of an Option Agreement to Acquire Gaspé Copper Mine From Glencore Canada

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

MONTREAL, March 28, 2022 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce that it signed, on March 25 2022, a binding term sheet with Glencore Canada Corporation (“Glencore” and collectively the “Parties”), providing Osisko Metals with an option (the “Option”) to acquire a 100% interest in the past-producing Gaspé Copper Mine (“Gaspé Copper”) located near Murdochville, Québec for an up-front payment of US$25 million, to be paid by Osisko Metals by way of a convertible note issued to Glencore upon the successful closing of the transaction, and a cash payment of US$20 million, payable upon start of commercial production. The Company must also incur drilling costs of C$5 million before June 30, 2022, to test oxidation levels within the...

Form 8.3 – [Clinigen Group plc – 25 03 2022] – (CGWL)

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CLINIGEN GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing undertaken: For...

Form 8.3 – [CareTech Holdings plc – 25 03 2022] – (CGWL)

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Buybacks of shares in Bilia AB during week 12, 2022

Written by Customer Service on March 28, 2022. Posted in Public Companies.

During the period between March 21-25, 2022 Bilia AB (LEI code 2138002GW5WN1UYZA032) has repurchased in total 235,706 own shares (ISIN SE0009921588 ) as part of the buyback program initiated by the Board of Directors in order to optimize the company’s capital structure. The share buybacks form a part of the buyback program of a maximum of 3,000,000 shares for a total maximum amount of SEK 500 M, which Bilia AB announced on January 19, 2022. The buyback program, which runs between February 9, 2022 – April 7, 2022, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the ”Safe Harbour Regulation”). The objective of the share buybacks is to optimize the company’s capital structure and the intention is to reduce Bilia’s share capital through...

Auction result of Treasury Bills – RIKV 22 0518 – RIKV 22 0720

Written by Customer Service on March 28, 2022. Posted in Public Companies.

Series RIKV 22 0518 RIKV 22 0720Settlement Date 03/30/2022 03/30/2022Total Amount Allocated (MM) 15,000 6,500All Bids Awarded At (Price / Simple interest) 99.587 / 3.047 98.923 / 3.499Total Number of Bids Received 9 7Total Amount of All Bids Received (MM) 15,600 7,400Total Number of Successful Bids 7 5Number of Bids Allocated in Full 7 5Lowest Price / Highest Simple Interest Allocated 99.587 / 3.047 98.923 / 3.499Highest Price / Lowest Simple Interest Allocated 99.596 / 2.980 98.999 / 3.250Lowest Price / Highest Simple Interest Allocated in Full 99.587 / 3.047 98.923 / 3.499Weighted Average of Successful Bids (Price/Simple Interest) 99.593 / 3.002 98.941 / 3.440Best Bid (Price / Simple Interest) 99.596 / 2.980 98.999 / 3.250Worst Bid (Price / Simple Interest) 99.438 / 4.152 98.892 / 3.601Weighted...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals